Irvine Scientific Expands in Southern California – Adds New Center of Excellence for Research and Development

Jun 13, 2017 | Posted in Corporate The Company adds a fifth building in California to expand R&D capabilities SANTA ANA, California – JUNE 13, 2017: Irvine Scientific, a world leader in the development and manufacture of cell culture media, today announced the expansion of its Orange County, California offices and laboratories, with the addition... Read more

FlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration

Leaders in flow cytometry tools collaborate to deliver cloud data management capabilities and streamline experimental execution June 13, 2017 03:59 AM Pacific Daylight Time ASHLAND, Ore. & FRANKLIN LAKES, N.J.–(BUSINESS WIRE)–FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data, and global medical technology... Read more

Oxford Instruments plc Appointment of Senior Independent Director

13 June 2017 Oxford Instruments plc, a leading provider of high-technology solutions, information and services for industry and research, is pleased to announce the appointment of Stephen Blair as an Independent Non-Executive Director. He will join the Board from [3 July] 2017 and will also take on the role of Senior Independent Director. Steve was... Read more

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

HERCULES, Calif. — June 12, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex® 2200 Syphilis Total & RPR assay, a novel one-step universal testing method to aid in the diagnosis of... Read more

New Immobilized Lux Chiral LC-SFC Selector from Phenomenex Delivers Broad Enantioselectivity

Torrance, Calif. (June 12, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, expands its Lux chiral LC/SFC column family with new immobilized Lux 5µm i-Amylose-1 and Lux 3µm i-Amylose-1 media. During the manufacturing of Lux immobilized media, a chemical crosslinking is formed between the... Read more

Cytapex and FlowJo, LLC Collaborate to Provide Informatics Services for Flow Cytometry

Leaders in flow cytometry informatics collaborate to deliver comprehensive services complementing the leading software platform June 12, 2017 01:24 PM Pacific Daylight Time BURNABY, British Columbia & ASHLAND, Ore.–(BUSINESS WIRE)–FlowJo, LLC, a single-cell data informatics and data analysis company with 20 years of experience, announced a partnership with Cytapex Bioinformatics, Inc. to provide bioinformatics consulting... Read more

MKS Instruments Makes a Voluntary $50 Million Prepayment on its Term Loan

ANDOVER, Mass., July 11, 2017 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today made a $50 million voluntary principal prepayment on its term loan. This prepayment is in addition to a scheduled principal payment of $1.6 million, and reduces the outstanding principal amount... Read more

QIAGEN’s QuantiFERON®-TB Gold Plus gains U.S. FDA approval

Fourth generation Latent TB blood test combines breakthrough CD4/CD8 design for comprehensive immune response detection with the most flexible blood collection workflow Germantown, Maryland, and Hilden, Germany, June 8, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) the fourth generation of the market... Read more

Waters and Andrews Alliance Sign Co-Marketing Agreement: Firms to Co-Market New Semi-Automated Sample Preparation Approach for Protein Therapeutics Glycosylation Profiling

Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that... Read more

Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil

Clinical laboratories now have access to enhanced levels of selectivity, sensitivity, and versatility from Waters’ newest UPLC-MS/MS technologies MILFORD, Mass.–(BUSINESS WIRE)–Jun. 8, 2017– Waters Corporation (NYSE: WAT) today announced that Brazil’sNational Health Surveillance Agency (ANVISA) has approved the Waters® ACQUITY® UPLC®, ACQUITY UPLC® I-Class System, and three mass spectrometers, the Xevo® TQD, Xevo TQ-S micro,... Read more